Sonendo, Inc. (SONX)
- Sector
- Healthcare
- Industry
- Medical Devices
- Last price
- $1.28
- As of
Kresmion compiles this page from SONX's SEC filings, its 13F institutional holders and the market events Kresmion detects, each linked to its source.
Sonendo, Inc. (SONX): no institutional manager tracked by Kresmion reported a non-option position in the latest Form 13F reporting quarter, and the most recent SEC filing on record for the company is a Form 10-K filed 2025-03-26.
See the full SONX dossier
Price with insider and filing markers, who is positioning, fundamentals and peers for SONX on one page. Preview it with sample data, then open it live with a free account.
Preview the SONX dossierActive signals for SONX
- mediumEARNINGS_MISS
Q1-2024: Missed consensus by 241.6% - EPS $-26 vs $18.36 estimate
- mediumEARNINGS_BEAT
Q2-2024: Beat consensus by 34.6% - EPS $-16 vs $-24.48 estimate
- mediumEARNINGS_BEAT
Q3-2024: Beat consensus by 22.7% - EPS $-15.77 vs $-20.4 estimate
- mediumEARNINGS_MISS
Missed consensus by 241.6% - EPS $-26 vs $18.36 estimate
- mediumEARNINGS_BEAT
Beat consensus by 34.6% - EPS $-16 vs $-24.48 estimate
FREE, NO ACCOUNT
Every signal on SONX, as it fires
You are seeing 5 of 6 signals recorded on SONX since 2026-05-30.
The five above landed across 2 days. The other 1 were recorded on those same days.
No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.
No non-option holdings from tracked managers in this reporting quarter. Historical quarters remain available above.
Recent SEC filings, SONX
- 10-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
SONX against its peers
SONX's operating margin of -92.6% ranks in the 50th percentile of 6 Medical Devices sub-industry peers, fiscal periods ending between 2024-09-30 and 2025-05-31.
| Metric | SONX | Peer median | Percentile | n |
|---|---|---|---|---|
| Revenue FY | 31.7M USD | 4.3M USD | 79 | 6 |
| Gross margin | 37.4% | 39.2% | 50 | 6 |
| Operating margin | -92.6% | -65.6% | 50 | 6 |
| Net margin | -88.4% | -50.7% | 44 | 7 |
| Return on equity | -540.0% | -26.5% | 8 | 5 |
Peers (8): TRIB, STME, TANAF, WOK, ADMT, ICCM, BMRA, POAS. Left out: USAQ (period gap), AIDX (period gap), VVOS (period gap), INBS (period gap), NXL (period gap), NVNO (period gap), PMEDF (period gap), ADGM (period gap), KLYG (no annual filing), AMIX (period gap), IVF (period gap), BJDX (period gap), CYDX (no annual filing), VNRX (period gap), CODX (period gap), NUWE (period gap), AEMD (period gap). Fiscal periods ending between 2024-09-30 and 2025-05-31. Every figure is one full fiscal year read from one annual filing (SONX: 10-K), reported in USD. Nothing is trailing twelve months and nothing is converted between currencies. Source: SEC EDGAR XBRL company facts (public domain); prices from Kresmion's daily equity market-data snapshot. Open the full comparison.
Related tickers
Follow SONX on a live board
Kresmion is a cross-asset market-intelligence terminal. Open a board scoped to SONX for its filings, 13F changes, insider trades, options positioning, and confluence read in one view, each with its source.